Medlander Reports H1 2025 Revenue of RMB 241 Million, Net Profit Down 12% Year-on-Year

Sep 05, 2025 16:01 CST Updated 16:01

Medlander

Developer of Intelligent Pelvic Floor Rehabilitation Diagnosis and Treatment System Products

On August 26, 2025, Medlander (688273.SH) announcedIn the H1 2025 financial report, the company achieved operating revenue of 241 million yuan, a year-on-year increase of 5.62%; net profit attributable to shareholders of 63.9201 million yuan, a year-on-year decrease of 11.96%; non-recurring net profit attributable to shareholders of 60.723 million yuan, a year-on-year decrease of 8.08%.

It is reported that, in H1 2025Pelvic floor rehabilitation contributes 39.39%.Achieve RevenueRMB 89,204,400；Consumables and AccessoriesContributionAccounting for 28.12%, reproductive rehabilitationContributionAccounting for 25.81%, Sports RehabilitationContributionAccounting for 4.25%, other contributions account for 2.42%.Medlander asChina Intelligent Pelvic Floor Reproductive Rehabilitation Diagnosis and TreatmentThe leading brand in the industry, focusing onPelvic Floor Treatment DeviceResearch and development, production, sales and service, while providingFemale Reproductive Anti-AgingOverall solution in the field.Main products include biofeedback stimulators, pelvic floor ultrasound devices, magnetic stimulators, high-frequency evaluation and electrocautery units, pelvic floor trainers, portable postpartum recovery devices, home-use pelvic floor rehabilitation therapy devices, biofeedback stimulators, high-frequency evaluation and electrocautery units, ultrasonic uterine involution devices, electro-ultrasound therapy devices, and Meiji.3D Skin Analyzer, Portable Handheld Skin Tester, Finger Joint Rehabilitation Assessment System, Portable Hand Function Rehabilitation Assessment System, Hand Function Magnetic Stimulation System, Biofeedback Stimulator, Portable Biofeedback Stimulator, Vaginal Electrode, Rectal Electrode, Vaginal Probe, etc.In terms of consumer healthcare, the company actively deploys in-home solutions.Medical Devices and Anti-Aging Field, offering private testing + anti-aging, reproductive + facial integrated solutions to meet women's health and beauty needs, has successively invested inYisu Medical, Aotong Laser, Xiaofu Technology, the layout of medical beauty products has been completed, preliminarily fulfilling the strategic planning of health and beauty, laying a foundation for the medium and long-term development of the company.

About Medlander

Medlander Medical Technology Inc. was founded inIn 2013, Medlander Medical Technology Inc. was established as a provider of physical rehabilitation intervention technology solutions for the entire life cycle of women in China. The company is mainly engaged in the research, development, production, and sales of products related to pelvic floor and postpartum rehabilitation, forming a series of medical pelvic floor, postpartum recovery, and home-use products. It has been successively recognized as a national specialized, refined, distinctive, and innovative "little giant" enterprise, a national manufacturing single-item champion demonstration enterprise, and successfully listed on the STAR Market on August 11, 2022, with the stock code: 688273.

MedlanderMedlanderBuilding on the foundation of pelvic floor and postpartum rehabilitation, the company further expands into fields such as reproductive rehabilitation, sports rehabilitation, nutrition, and health management, striving to become a world-class healthcare company dedicated to women's health and beauty.It now has product lines including pelvic floor and postpartum rehabilitation equipment, reproductive rehabilitation equipment, consumables and accessories, health management information systems, etc., which are widely used in medical and health fields such as obstetrics and gynecology, pelvic floor rehabilitation, reproductive rehabilitation, urology and proctology, and physical examination.

In the field of postpartum rehabilitation, mainly focusing on gynecological and obstetric rehabilitation, postpartum recovery, and the diagnosis and treatment of pelvic floor functional disorders. The products mainly include: biofeedback stimulators, pelvic floor ultrasound, magnetic stimulators, high-frequency evaluation electrosurgical units, pelvic floor trainers, portable postpartum recovery devices, and home-use pelvic floor rehabilitation therapy devices, which are widely used in departments such as gynecology, pelvic floor rehabilitation centers, urology, and proctology in hospitals.

In the field of reproductive rehabilitation, mainly for the adjuvant treatment of post-abortion surgery, post-hysteroscopic surgery, infertility, premature ovarian failure, etc. The products mainly include: biofeedback stimulators, high-frequency evaluation and electrocautery devices, ultrasonic uterine restoration devices, electro-ultrasound therapy devices, etc., applied in gynecology, obstetrics, reproductive centers, medical cosmetology institutions, and other fields in hospitals.

In the field of sports rehabilitation, mainly targeting motor function disorders and hand function assessment and rehabilitation for people with cerebral palsy and post-stroke. The products mainly include: Finger Joint Rehabilitation Assessment System, Portable Hand Function Rehabilitation Assessment System, Hand Function Magnetic Stimulation System, Biofeedback Stimulator, Portable Biofeedback Stimulator, applied in the rehabilitation department, pediatric rehabilitation department, neurology department, orthopedic department, and geriatric department.

In addition, Medlander has also strengthened the competitiveness of its rehabilitation product line through mergers, acquisitions, and investments.Horizontal Layout in Other Medical Aesthetics TracksSince 2019, investments have been made successively.Oubao Xiang, Yisu Medical, Aotong Laser, Xiaofu Technology, laying out plans for injection-molded parts, female reproductive rehabilitation products, laser equipment, and technological skin testing, thereby establishing a foundation for the long-term strategic planning of health and beauty.

On October 24, 2023, Medlander completed the acquisition of 100% equity in Shanghai Aotong Laser.It is reported that Aotong Laser is a high-tech enterprise specializing in the development, production, and operation of laser medical equipment. It is committed to providing comprehensive laser, photon medical, and beauty solutions to users across China and other regions worldwide, including high-performance equipment, comprehensive technical support, and continuous clinical support.

On January 26, 2024, Medlander completed the acquisition of 55% equity in Hangzhou Xiaofu Technology.It is reported that Xiaofu Technology is a company that has taken the lead in completing the deep integration of imaging acquisition hardware, application software, underlying analysis algorithms, and business scenarios in the fields of 3D facial modeling and AI skin and morphology analysis. It provides customers with integrated medical aesthetics digital diagnosis and solutions. Its core product, "Meiji 3D Skin Analyzer," now serves more than 1,200 leading medical aesthetic institutions across China.

On June 6, 2024, the overall structural construction of Medlander Medical Technology Inc.'s headquarters R&D and production base project was completed, achieving the topping out of the main structure.It is reported that the headquarters R&D and production base of Medlander officially commenced construction on December 31, 2022. Covering an area of 44 mu, with a total building area of 90,000 square meters and a total investment exceeding 500 million yuan, the park integrates R&D, production, assembly, debugging, warehousing, office, and living facilities.

July 5, 2024Medlander andBeautiful Land signs strategic cooperation agreement, Both parties will join hands to deepen cooperation in sharing R&D resources for female gynecological anti-aging, and jointly promote the industry to a higher level. It is reported that the two partiesWill share gynecological anti-aging research achievements, technologies, and market information, promote industry technological innovation and industrial upgrading, and provide female customers with more professional and personalized solutions.

On February 28, 2025, Medlander's self-developed Class II "Ultrasonic Therapy Device" was officially approved by the Jiangsu Provincial Drug Administration., Registration Certificate No.: Su Medical Device Registration Approval 20252090332According to reports, up to now, two Class II ultrasound therapy devices for "skin tightening and wrinkle removal" have been approved in China.Exclusively distributed by Jingyan BiotechMFU pro"MeramayUltrasonic Scalpel(Yu Medical Device Registration Approval 20242090073) andGuizhou Perlead MedicalBolidaPolida®"Platinum Ultrasound Cannon"(Qian Medical Device Registration No. 20242090048),Medlander's "Ultrasonic Therapy Device" is approved in China.The 3rd-Generation Ultrasound Therapy Device for Medical Aesthetics Compliant Indications。

On March 12, 2025, Medlander's reproductive anti-aging brand Weizhilan®Strategic Cooperation Release Conference with Yuansong Group Held at Yuansong Medical Aesthetics in Chengdu, and Unveiling Ceremony"Chengdu Yuansong Research and Training Benchmark Base", marking the private medical aesthetics industry from"Technological Iteration" Enters a New Phase of "Ecosystem Co-construction".